Medsi AI’s Platform Is Approved as the First Class II Software as a Medical Device (SaMD) for Preventive Health in the Western Hemisphere

Medsi AI’s Platform Is Approved as the First Class II Software as a Medical Device (SaMD) for Preventive Health in the Western Hemisphere PRNewswire-PRWeb/ — Medsi AI (www.medsi.ai), a Mexican Health 3.0 innovator, today announced the launch of a groundbreaking digital health platform powered… Read More from the Global Wellness News ™

Samphire Neuroscience Raises $5M Seed Round for Novel Neurotech Wearable Targeting Menstrual Pain

Samphire Neuroscience Raises $5M Seed Round for Novel Neurotech Wearable Targeting Menstrual Pain Samphire Neuroscience has raised $5 million in seed funding to expand its Nettle brain device for menstrual symptoms, following strong market reception since its European launch earlier this year. The round was led by Nordic venture capital firm Inventure VC, with participation from US-based Fortify Ventures. Read More from the Global Wellness News…

Middle East Travel Spending to Hit 350 Billion USD by 2030 Amid Surge in Business, Luxury and Sports Tourism

Middle East Travel Spending to Hit 350 Billion USD by 2030 Amid Surge in Business, Luxury and Sports Tourism – Travel And Tour World Middle East travel spend will grow 50% by 2030 to $350B, driven by luxury, business, and sports tourism, according to ATM and Tourism Economics report. Read More from the Global Wellness News ™